文献速递临床生化临床免疫

铁人三项运动员代谢与生长相关生物标志物的生物学变异数据

Biological Variation Data in Triathletes for Metabolism and Growth-Related Biomarkers Included in the Athlete Biological Passport.
PubMed 文献 · Clin Chem · 2024-01-01

贝叶斯法CVI从IGFBP-3的7.8%到胰岛素的27.0%,两模型除P-III-NP外结果相似。除胰岛素外所有指标个体性指数低于0.6,IGF-1和IGFBP-3需性别特异性CVI。

要点

  • 运动员群体中胰岛素可应用统一CVI,IGF-1和IGFBP-3应使用性别特异性估计。
  • P-III-NP数据呈异质性分布,使用平均CVI可能不具代表性。
  • IGF-1、IGFBP-3和P-III-NP个体性程度高,适合通过参考变化值和ABP解读。

核心结论

  • 运动员群体中胰岛素适用统一CVI,IGF-1和IGFBP-3应使用性别特异性CVI。
  • P-III-NP数据异质性分布,平均CVI可能不具群体代表性。
  • IGF-1、IGFBP-3和P-III-NP个体性高,适合用参考变化值和ABP解读。

研究设计与样本

  • 采用免疫法检测hGH、IGF-1、IGFBP-3、胰岛素和P-III-NP。
  • 应用贝叶斯和ANOVA方法估计个体内和个体间生物学变异。

主要发现

  • 贝叶斯法CVI从IGFBP-3的7.8%到胰岛素的27.0%。
  • 两模型结果相似,但P-III-NP除外。
  • P-III-NP在总体人群和女性IGF-1、IGFBP-3中呈异质性分布。
  • hGH因缺乏稳态未估计生物学变异组分。
  • 除胰岛素外所有指标个体性指数低于0.6。

关键数值与推荐

  • 贝叶斯法CVI:IGFBP-3为7.8%,胰岛素为27.0%。
  • 除胰岛素外所有指标个体性指数低于0.6。

临床怎么用

  • 运动员群体中胰岛素可使用统一CVI进行解读。
  • IGF-1和IGFBP-3应使用性别特异性CVI。
  • P-III-NP不宜使用平均CVI代表群体。
  • IGF-1、IGFBP-3和P-III-NP适合通过参考变化值和ABP解读。

局限性

  • hGH因缺乏稳态未估计生物学变异组分。
  • P-III-NP数据呈异质性分布,平均CVI可能不具代表性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: When using biological variation (BV) data, BV estimates need to be robust and representative. High-endurance athletes represent a population under special physiological conditions, which could influence BV estimates. Our study aimed to estimate BV in athletes for metabolism and growth-related biomarkers involved in the Athlete Biological Passport (ABP), by 2 different statistical models. METHODS: Thirty triathletes were sampled monthly for 11 months. The samples were analyzed for human growth hormone (hGH), insulin-like growth factor-1 (IGF-1), insulin-like growth factor binding protein 3 (IGFBP-3), insulin, and N-terminal propeptide of type III procollagen (P-III-NP) by immunoassay. Bayesian and ANOVA methods were applied to estimate within-subject (CVI) and between-subject BV. RESULTS: CVI estimates ranged from 7.8% for IGFBP-3 to 27.0% for insulin, when derived by the Bayesian method. The 2 models gave similar results, except for P-III-NP. Data were heterogeneously distributed for P-III-NP for the overall population and in females for IGF-1 and IGFBP-3. BV components were not estimated for hGH due to lack of steady state. The index of individuality was below 0.6 for all measurands, except for insulin. CONCLUSIONS: In an athlete population, to apply a common CVI for insulin would be appropriate, but for IGF-1 and IGFBP-3 gender-specific estimates should be applied. P-III-NP data were heterogeneously distributed and using a mean CVI may not be representative for the population. The high degree of individuality for IGF-1, IGFBP-3, and P-III-NP makes them good candidates to be interpreted through reference change values and the ABP.

来源:Clin Chem,查看原文。版权归原作者所有。

引用

  1. Moreno-Parro I, Diaz-Garzon J, Aarsand AK, et al. Biological Variation Data in Triathletes for Metabolism and Growth-Related Biomarkers Included in the Athlete Biological Passport. Clin Chem. 2024. PMID: 38781424. doi:10.1093/clinchem/hvae072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。